파트너십
"충족되지 못한 의학적 요구를 해결할 수 있도록 선도적인 생체의약품 기업들과 과학적 상승 효과 분야를 찾기 위한 기회를 지속적으로 추구하고 있습니다. 제휴 및 협업을 통해서 Calla Lily Clinical Care 기기를 전적으로 활용해 다른 다양한 약물/호르몬/치료제를 표적화하고 전달할 수 있습니다."
NIHR
Calla Lily Clinical Care has secured £1 million in funding from the National Institute for Health and Care Research (NIHR) to advance our pioneering Callavid® technology addressing threatened miscarriage. This partnership enables us to begin first-in-person clinical trials and marks a crucial milestone in our mission to transform care for women experiencing threatened miscarriage.
Innovate UK
Calla Lily Clinical Care has been generously supported by Innovate UK—the UK government’s innovation agency—through both its SMART and BioMedical Catalyst funding programmes.
UHCW
Calla Lily Clinical Care is collaborating with University Hospitals Coventry and Warwickshire (UHCW) NHS Trust on a clinical trial of our innovative progesterone delivery device, Callavid®. Led by Professor Siobhan Quenby MBE, a leading expert in miscarriage and preterm birth, the NIHR-funded feasibility study is scheduled for the second half of 2025.
University of Warwick
Our partnership with the University of Warwick establishes a fully funded 4-year MSc/PhD program dedicated to advancing scientific research in vaginal microbiota and women's reproductive health. This collaborative research initiative explores the critical mechanisms by which vaginal microbiota protect against inflammation and pregnancy complications
Queen Mary University of London
Our partnership with Queen Mary University of London advances critical research in women's reproductive health through an innovative PhD studentship focused on developing breakthrough solutions for bacterial vaginosis. Combining our clinical expertise with the university's leading bioengineering capabilities, we are developing a novel microbiome organ-chip model to explore probiotic interventions that could transform treatment approaches for a condition affecting 30% of reproductive-aged women
UCL / UCL Consultants Ltd
We have established a multiyear partnership with UCL Consultants Ltd, working closely with Professor Catherine Tuleu's team to advance drug formulation technology for our Callavid® device.
제휴 및 기타 사업 개발 기회에 대한 자세한 내용은 info@callali.ly 또는 전화 +44 (0) 20 7754 5400으로 문의하시기 바랍니다.